Magnetic Resonance Imaging at Different Levels of Magnetic Intensity
Launched by NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (NHLBI) · Nov 3, 1999
Trial Information
Current as of May 09, 2025
Completed
Keywords
ClinConnect Summary
Technical evaluation of magnetic resonance imaging and spectroscopy will be performed on normal volunteers. These studies will be conducted in the MRI systems located at the NIH. These studies may involve the intravenous administration of commercially available MR contrast media and exercise. The results will be used to evaluate the performance of various pulse sequences, gradient coils, and RF coils on human subjects and will provide essential ground work for specific patient protocols.
Gender
ALL
Eligibility criteria
- * INCLUSION CRITERIA:
- • Any normal volunteer greater than or equal to 18 who is capable of giving informed consent.
- EXCLUSION CRITERIA:
- A subject will be excluded if he/she has a contraindication to MR scanning such as:
- • 1. Brain aneurysm clip
- • 2. Implanted neural stimulator
- • 3. Implanted cardiac pacemaker or defibrillator
- • 4. Cochlear or ear implant
- • 5. Ocular foreign body (e.g. metal shavings)
- • 6. Insulin pump
- • 7. Pregnant women (when uncertain, subject will undergo urine or blood testing).
- • 8. Claustrophobia
- • 9. Any condition in the Principal Investigator's judgement which present unnecessary risk
- EXCLUSION CRITERIA FOR GADOLINIUM ENHANCED STUDIES:
- • 1. Lactating Women
- • 2. Renal or hepatic disease
About National Heart, Lung, And Blood Institute (Nhlbi)
The National Heart, Lung, and Blood Institute (NHLBI) is a leading component of the National Institutes of Health (NIH), dedicated to advancing research and clinical trials focused on cardiovascular, pulmonary, and hematologic diseases. With a mission to improve public health through innovative research, the NHLBI supports a wide range of studies aimed at understanding, preventing, and treating heart and lung conditions. By collaborating with academic institutions, healthcare providers, and patient communities, the NHLBI strives to translate scientific discoveries into effective clinical practices, ultimately enhancing the quality of life for individuals affected by these critical health issues.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bethesda, Maryland, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials